Federated Hermes’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Buy |
|
|||||
|
2025
Q1 | $1.39M | Buy |
|
|||||
|
2024
Q4 | $1.25M | Sell |
|
|||||
|
2024
Q3 | $1.4M | Sell |
|
|||||
|
2024
Q2 | $1.66M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $308K | Sell |
|
|||||
|
2021
Q4 | $1.24M | Buy |
|
|||||
|
2021
Q3 | $392K | Sell |
|
|||||
|
2021
Q2 | $433K | Buy |
|
|||||
|
2021
Q1 | $341K | Sell |
|
|||||
|
2020
Q4 | $443K | Buy |
|
|||||
|
2020
Q3 | $283K | Sell |
|
|||||
|
2020
Q2 | $6.62M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $3K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.34M | Hold |
|
|||||
|
2018
Q1 | $1.15M | Buy |
|
|||||
|
2017
Q4 | $535K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.84M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $828K | Sell |
|
|||||
|
2016
Q3 | $1.48M | Buy |
|
|||||
|
2016
Q2 | $1.09M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $138K | Buy |
|